Literature DB >> 18573292

History of influenza vaccination programs in Japan.

Yoshio Hirota1, Masaro Kaji.   

Abstract

In 1976, influenza mass vaccination among schoolchildren was started under the Preventive Vaccination Law, which was intended to control epidemics in the community. However, in the late 1980s, questions about this policy and vaccine efficacy arose, and a campaign against vaccination began. In 1994, influenza was excluded from the target diseases list in the Preventive Vaccination Law, without considering the immunization policy with respect to the common indications in high-risk groups. In 2001, the Law was again amended, specifying target groups, such as the elderly aged 65 or over, for influenza vaccination. In the 2005--2006 season, vaccine coverage among the elderly reached 52%. This shows that the need for vaccination has gradually become understood. However, the anti-vaccination campaign, which claims that the influenza vaccine has no efficacy, is still active. Vaccine efficacy studies that were not properly conducted are also being reported. In 2002, the Ministry of Health, Labor, and Welfare organized a research group on vaccine efficacy consisting of epidemiologists. The present symposium, as part of the 9th Annual Meeting of the Japanese Society for Vaccinology in 2005, was planned to further introduce epidemiological concepts useful in studying influenza vaccine efficacy.

Mesh:

Substances:

Year:  2008        PMID: 18573292     DOI: 10.1016/j.vaccine.2008.06.042

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Longitudinal surveillance of influenza in Japan, 2006-2016.

Authors:  Shinako Inaida; Shigeo Matsuno; Jiro Okumura
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

2.  Demand for pneumococcal vaccination under subsidy program for the elderly in Japan.

Authors:  Masahide Kondo; Mariko Yamamura; Shu-Ling Hoshi; Ichiro Okubo
Journal:  BMC Health Serv Res       Date:  2012-09-12       Impact factor: 2.655

3.  Factors associated with influenza vaccination status of residents of a rural community in Japan.

Authors:  Daisuke Matsui; Masako Shigeta; Kotaro Ozasa; Nagato Kuriyama; Isao Watanabe; Yoshiyuki Watanabe
Journal:  BMC Public Health       Date:  2011-03-04       Impact factor: 3.295

4.  Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildren.

Authors:  Vivek Charu; Cécile Viboud; Lone Simonsen; Katharine Sturm-Ramirez; Masayoshi Shinjoh; Gerardo Chowell; Mark Miller; Norio Sugaya
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

5.  Factors associated with seasonal influenza vaccine uptake among children in Japan.

Authors:  Aiko Shono; Masahide Kondo
Journal:  BMC Infect Dis       Date:  2015-02-18       Impact factor: 3.090

6.  Mistrust surrounding vaccination recommendations by the Japanese government: results from a national survey of working-age individuals.

Authors:  Koji Wada; Derek R Smith
Journal:  BMC Public Health       Date:  2015-04-26       Impact factor: 3.295

7.  Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010.

Authors:  Ritsuko Kubota-Koketsu; Mikihiro Yunoki; Yoshinobu Okuno; Kazuyoshi Ikuta
Journal:  Biologics       Date:  2012-07-27

8.  Influenza vaccination uptake among the working age population of Japan: results from a national cross-sectional survey.

Authors:  Koji Wada; Derek R Smith
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

9.  Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older.

Authors:  Hideyuki Ikematsu; Kazuyoshi Tenjinbaru; Ping Li; Anu Madan; David Vaughn
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

10.  Reasons for and against receiving influenza vaccination in a working age population in Japan: a national cross-sectional study.

Authors:  Tsubasa Iwasa; Koji Wada
Journal:  BMC Public Health       Date:  2013-07-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.